Pictet Asset Management Holding SA »

BioMarin Pharmaceutical shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $65M 920k 70.36
2024-03-31 $167M 1.9M 87.53

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical